Friday, May 10, 2013

• BioSante Pharmaceuticals, Inc. Reports First Quarter Financial ResultsBusiness Wire( (Fri, May 10)

Wednesday, May 8, 2013

• BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Special Meetings of Stockholders to Consider Proposed MergerBusiness Wire( (Wed, May 8)

Friday, April 19, 2013

• Ceregene Reports Data From Parkinson's Disease Phase 2b StudyPR Newswire( (Fri, Apr 19)

Friday, April 12, 2013

• BioSante Pharmaceuticals, Inc. and ANI Pharmaceuticals, Inc. Announce New Merger AgreementBusiness Wire( (Fri, Apr 12)

Tuesday, March 19, 2013

• BioSante Pharmaceuticals, Inc. Sends Letter Urging Stockholders to Vote “FOR” Proposed Merger with ANI Pharmaceuticals, Inc.Business Wire( (Tue, Mar 19)

Friday, March 15, 2013

• BioSante Pharmaceuticals Announces Adjournment of Its Stockholders Meeting Until April 12, 2013Business Wire( (Fri, Mar 15)

Wednesday, March 13, 2013

• Ceregene And Alzheimer's Disease Cooperative Study Group Complete Enrollment Of CERE-110 Phase 2 TrialPR Newswire( (Wed, Mar 13)

Tuesday, March 12, 2013

• Biotech Industry Looks to Benefit From FDA's New "Breakthrough" DesignationMarketwired( (Tue, Mar 12)

Monday, March 4, 2013

• Glass, Lewis & Co., LLC Recommends Vote “FOR” BioSante/ANI MergerBusiness Wire( (Mon, Mar 4)

Friday, March 1, 2013

• BioSante Pharmaceuticals Provides Merger Update and Reports 2012 Financial ResultsBusiness Wire( (Fri, Mar 1)

Tuesday, February 26, 2013

• Leading Independent Proxy Advisory Firm ISS Joins Egan-Jones in Recommending “FOR” BioSante/ANI MergerBusiness Wire( (Tue, Feb 26)

Tuesday, February 19, 2013

• Egan-Jones Proxy Services Recommends Stockholders Vote “FOR” BioSante and ANI MergerBusiness Wire( (Tue, Feb 19)

Friday, February 1, 2013

• Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year HighMarketwired( (Fri, Feb 1)